Mayne Pharma (ASX:MYX) posts another half-yearly loss, hits seven-year low
- ASX 200 pharmaceutical company Mayne Pharma (MYX) has posted a $17.5 million loss in its latest half-yearly report
- Fierce overseas competition drove revenue, earnings, and profits down for the company compared to the same time the year before
- However, with some severe business restructuring, today's loss is not as heavy as January to June 2019
Posts another half-yearly loss, hits seven-year low
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.48 |
Change
-0.300(6.28%) |
Mkt cap ! $381.1M | |||
| Open | High | Low | Value | Volume |
| $4.77 | $4.80 | $4.48 | $2.306M | 500.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 19554 | $4.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.51 | 191 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.49 |
Change
-0.300 ( 6.26 %) |
||||
| Open | High | Low | Volume | ||
| $4.77 | $4.80 | $4.49 | 52783 | ||
| Last updated 15.59pm 13/06/2024 ? | |||||
| MYX (ASX) Chart |